Neurobiology of Huntington’s Disease: Applications to Drug Discovery (Frontiers in Neuroscience) - Image 1

£74.99

CRC Press Neurobiology of Huntington’s Disease: Applications to Drug Discovery (Frontiers in Neuroscience)

Name: Neurobiology of Huntington's Disease: Applications to Drug Discovery (Frontiers in Neuroscience)
Brand: CRC Press
Price: 74.99 GBP
Availability: InStock

Pharmacy - Dispensing

It has never been this cheap. We have no record of a lower price.

£75 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 1 days • 1 data points (No recent data available)

Historical

Generating forecast...

Not enough data points to display chart (need at least 2 points)

Price Distribution

Price distribution over 1 days • 1 price levels

Days at Price

Price Analysis

Most common price: £75 (1 days, 100.0%)

Price range: £75 - £75

Price levels: 1 different prices over 1 days

Description

In 1993, the genetic mutation responsible for Huntington’s disease (HD) was identified. Considered a milestone in human genomics, this discovery has led to nearly two decades of remarkable progress that has greatly increased our knowledge of HD, and documented an unexpectedly large and diverse range of biochemical and genetic perturbations that seem to result directly from the expression of the mutant huntingtin gene. Neurobiology of Huntington’s Disease: Applications to Drug Discovery presents a thorough review of the issues surrounding drug discovery and development for the treatment of this paradigmatic neurodegenerative disease. Drawing on the expertise of key researchers in the field, the book discusses the basic neurobiology of Huntington’s disease and how its monogenic nature confers enormous practical advantages for translational research, including the creation of robust experimental tools, models, and assays to facilitate discovery and validation of molecular targets and drug candidates for HD. Written to support future basic research as well as drug development efforts, this volume: Covers the latest research approaches in genetics, genomics, and proteomics, including high-throughput and high-content screening Highlights advances in the discovery and development of new drug therapies for neurodegenerative disorders Examines the practical realities of preclinical testing, clinical testing strategies, and, ultimately, clinical usage While the development of effective drug treatments for Huntington's disease continues to be tremendously challenging, a highly interactive and cooperative community of researchers and clinical investigators now brings us to the threshold of potential breakthroughs in the quest for therapeutic agents. The impressive array of drug discovery resources outlined in the text holds much promise for treating this devastating disease, providing hope to long-suffering Huntington’s disease patients and their families. Review The book is written lucidly by authorities in their respective fields, covering clinical features, pathogenic mechanisms, protein interactions, preclinical models, biomarkers, small molecules and other approaches (eg, recombinant antibodies), screening strategies, and drug development. Informative figures and tables are provided, and reproduction of key figures as a set of colour plates provides a useful centrepiece. One unifying message is that the polyglutamine xpansion leads to a complex cascade of diverse molecular and cellular events, the progress of which is difficult to slow or halt. Innovative approaches described, such as the target validation process of the Cure Huntington's Disease Initiative (CHDI) Foundation, will be of interest to those studying other neurological diseases.--Anthony J Hannan, writing in The Lancet Neurology, March 2011

Product Specifications

Brand: CRC Press
Format: Paperback
ASIN: 1138116629
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 31 October 2017
Listed Since: 12 May 2017

Barcode

No barcode data available

CRC Press Neurobiology of Huntington’s Disease: Applications to Drug Discovery (Frontiers in Neuroscience)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Neurobiology of Huntington's Disease: Applications to Drug Discovery (Frontiers in Neuroscience)

SPEC – Handbook of Clinical Neurology, Volume 144, Huntington Disease, 12-Month Access, eBook (Volume 144)

Polyglutamine Disorders: 1049 (Advances in Experimental Medicine and Biology, 1049)

Huntington’s Disease: Pathogenic Mechanisms and Implications for Therapeutics

Parkinson's Disease and Related Disorders, Part II (Volume 84) (Handbook of Clinical Neurology, Volume 84)

Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)

Food for Huntingtons Disease (Nutrition and Diet Research Pr)

Parkinson's Disease and Related Disorders Part I (Volume 83) (Handbook of Clinical Neurology, Volume 83)

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Fractured Minds: A Case-Study Approach to Clinical Neuropsychology

A Theory of the Basal Ganglia and Their Disorders: 8 (Conceptual Advances in Brain Research)

The Basal Ganglia IX: 58 (Advances in Behavioral Biology, 58)

Molecular Pathology of the Prions: 59 (Methods in Molecular Medicine)

Neurotoxic Factors in Parkinson’s Disease and Related Disorders

Mitochondrial Mechanisms of Degeneration and Repair in Parkinson's Disease

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (Enzyme Inhibitors)

Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (Contemporary Neuroscience)

Human Caspases and Neuronal Apoptosis in Neurodegenerative Diseases

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)

Neurodegenerative Disorders as Systemic Diseases

Functional Neural Transplantation IV: Translation to Clinical Application, Part A (Volume 230) (Progress in Brain Research, Volume 230)

Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, Seventh Edition: Volume 2 (Volume 2)